Bone, testosterone and glucose metabolism.
Recruiting
- Conditions
- Osteoporosis
- Registration Number
- NL-OMON27144
- Lead Sponsor
- Academic Medical Center (AMC) Amsterdam
- Brief Summary
A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 8
Inclusion Criteria
1. Male sex 50-80 years;
2. Recently diagnosed primary osteoporosis (T-score between -2.5 and -3.5);
Exclusion Criteria
1. Contraindication to parathyroid hormone therapy: hypersensitivity to the active substrate or to any of the excipients, pre-existing hypercalcaemia, hepatic- or renal insufficiency, metabolic bone diseases other than primary osteoporosis or glucocorticoid-induced osteoporosis, unexplained elevations of alkaline phosphatase, prior external beam or implant radiation therapy to the skeleton, patients with skeletal malignancies or bone metastases;
2. Any medication or disease influencing bone turnover;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method